Conrad Roten

2 months ago | drugdiscoveryonline.com | Becky Upton |David Lyon |Conrad Roten

The Pistoia Alliance conducted a survey as a pulse check on which technologies the pharma/biotech industry is investing in and companies' progress integrating new tech into the lab. Developing And Scaling Through Innovative TechnologiesWatch as Cambrex experts walk through a variety of technologies and case studies, focusing on LPPS, peptide crystallization, method development for peptide impurity analysis, and more.

Sep 10, 2024 | drugdiscoveryonline.com | Jie Huang |David Lyon |Conrad Roten

Bridge RNAs are structured noncoding RNAs that facilitate programmable recombination between target and donor DNA, enabling precise genomic rearrangements. A significant advantage is their modularity. Formulation Of Crystalline Nanoparticles Enabling Superior Drug LoadExplore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.